Bayer introduces medication for Chronic Kidney Disease
The drug is a non-steroidal, selective mineralocorticoid receptor antagonist indicated for patients with chronic kidney disease…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
KERENDIA
Bayer gets US FDA nod for KERENDIA (finerenone) to treat CKD associated with type 2 diabetes
It is a first-in-class nonsteroidal mineralocorticoid receptor antagonist (MRA) indicated to reduce the risk of sustained eGFR…